Dr Reddys unveils generic version of Rozerem Tablets in US for treating insomnia

The product is a therapeutically equivalent generic version of Rozerem (ramelteon, 8 mg) Tablets, approved by the U.S. Food and Drug Administration (USFDA).

New Delhi: Drugmaker, Dr Reddy’s Laboratories Ltd. has announced the launch of Ramelteon Tablets, 8 mg indicated for the treatment of insomnia in the US market.

The product is a therapeutically equivalent generic version of Rozerem (ramelteon, 8 mg) Tablets, approved by the U.S. Food and Drug Administration (USFDA).

Also Read: NPPA notices worth Rs 101 crore sent to Biocon, Lupin, Dr Reddys, others for skipping regulatory nod-Minister

Dr Reddy’s Ramelteon Tablets are available as 8 mg tablets in bottle count sizes of 30, 100, and 1000.

"Rozerem is a trademark of Takeda Pharmaceutical Company Limited," the drug major said

"The Rozerem brand had U.S. sales of approximately $91.3 million MAT for the most recent twelve months ending in May 2019 according to IQVIA Health," the company added.

Also Read: Dr Reddys unveils generic version of Allegra D in US to treat common cold, flu